Petros Pharmaceuticals (PTPI) said Tuesday it has priced a public offering of about 40 million shares, or pre-funded warrants, with each share accompanied by a Series A warrant to buy 0.25 share at an exercise price of $0.48 per 0.25 share, and a Series B warrant to buy one share at an exercise price of $0.48 per share.
The combined public offering price of each share with the accompanying Series A warrant and Series B warrant is $0.24, and the combined public offering price of each pre-funded warrant together with the accompanying Series A warrant and Series B warrant is $0.2399, Petros said.
The gross proceeds of the offering are expected to be $9.6 million, the company said.
Net proceeds of the offering, expected to close on or about Wednesday, will be used for working capital and general corporae purposes, the company said.
Price: 0.14, Change: -0.15, Percent Change: -51.19
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。